How TrialX’s Multilingual Capabilities Are Driving Global Clinical Trials
For decades, clinical trials have struggled with a deep-rooted problem: a lack of diversity. Racial and ethnic minorities, individuals in non-English-speaking communities, and patients outside of research-heavy geographies remain consistently underrepresented in studies. This isn’t just a statistic, it’s a barrier to equity and innovation. Treatments are often developed and approved without the data to understand how they affect all populations.
One of the most persistent — yet solvable — obstacles to inclusion is language and geographic barriers.
Despite advances in digital recruitment and decentralized trial models, many platforms still lack multilingual capabilities. This gap has real consequences. A study published in JNCI Cancer Spectrum surveyed 139 Children’s Oncology Group (COG) institutions and found that 47% of respondents had difficulty enrolling non-English-speaking participants. The main obstacles include limited funding for translation, restrictions on using translated consent forms, and a reliance on in-person interpreters, who are frequently unavailable. These limitations highlight a systemic shortfall: even when researchers are committed to inclusion, the infrastructure isn’t equipped to support it.
Enhancing Diversity & Inclusion in The Evolving Global Clinical Trials Landscape
In today’s globalized world, clinical trials are increasingly conducted across multiple countries and regions. Yet, the tools to recruit, engage, and retain participants across languages and cultures remain limited. The shift toward decentralized and hybrid clinical trials has opened the door to broader participant pools, but to truly make research inclusive, we must go further. At TrialX, we believe that meaningful participation should never be limited by geography or language.
To address this challenge, TrialX’s patient recruitment solution offers robust multilingual and multicountry features that empower sponsors and researchers to run inclusive campaigns and build global trials without losing local relevance.
Here’s how:
- Study websites and materials
Studies succeed when participants feel seen, understood, and included from the start. TrialX enables sponsors to create fully localized study experiences that resonate across languages and cultures, building trust. With this feature, sponsors can:
- Create trial landing pages in multiple languages
- Support multilingual prescreeners and eligibility forms
- Translate consent forms
For example, a study running in both Brazil and the U.S. might have a Portuguese website and prescreener targeting Brazilian patients, alongside an English or Spanish version for U.S.-based participants.
- Multilingual Recruitment Campaigns
With our platform, research teams can create and launch patient recruitment campaigns in up to 10 countries, supporting languages such as English, Spanish, French, Italian, Hindi, Portuguese, and German. Teams can easily tailor outreach across social media, email, and other channels to resonate with diverse populations.
By enabling custom messaging across languages and outreach types, we help ensure that trial information reaches participants in culturally relevant and easy—to—understand ways, boosting engagement, building trust, and accelerating recruitment.
- Multicountry Compliance
Running studies internationally also means navigating a complex landscape of regulations, from consent requirements to data protection laws. TrialX is designed to handle this complexity so researchers can stay focused on science and recruitment.
Multicountry features include:
- Compliance with local data privacy laws, including HIPAA, GDPR, and region-specific frameworks
- Time zone-aware scheduling and communications to align with participants and sites locally
These capabilities ensure that every participant, no matter where they live or what language they speak, experiences a study that is compliant, secure, and respectful of their local context.
Inclusion, Powered by Design
The future of clinical research is global, diverse, and digitally driven. TrialX is proud to power this future with technology that reflects the complexity and potential of the world we live in. Our multilingual and multicountry capabilities are more than a feature; they’re a commitment to inclusion by design.
Whether you’re running a single-site study or a global trial, TrialX equips you to reach the right participants, in the right language, wherever they are.
Ready to launch a more inclusive trial?
Learn how TrialX can support your global study needs. Contact us here.
